A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI – GINECO study

Florence Joly, Michel Fabbro, Philippe Follana, Justine Lequesne, Jacques Médioni, Anne Lesoin, Jean‐Sébastien Frenel, Sophie Abadie‐Lacourtoisie, Anne Floquet, Laurence Gladieff, Benoît You, Céline Gavoille, Elsa Kalbacher, Mélanie Briand, Pierre-Emmanuel Brachet, Florence Giffard, Louis‐Bastien Weiswald, Pierre‐Alexandre Just, Cécile Blanc‐Fournier, Alexandra Leconte, Bénédicte Clarisse, Alexandra Léary, Laurent Poulain